6
t h
A n n u a l E u r o p e a n C o n f e r e n c e o n
Gastroenterology
Euro Gastro 2018
J u n e 1 9 - 2 0 , 2 0 1 8
P a r i s , F r a n c e
Page 28
Journal of Clinical Gastroenterology and Hepatology
ISSN 2575-7733
Aim:
The aim of this study is to observe perioperative surgical treatment and
experience with gastric sleeve resection (GSR) in patients with “body mass
index” equal or higher than 70 kg /m
2
(BMI ≥ 70 kg/m
2
) known as a “mega
obese” (MO).
Methods:
In 105 screened “super obese” patients with GSR, 4 MO patients
(3.18%) with postoperative follow up from 3 to 108 months have been found
during the period of 9 years.
Results:
Preoperative mean BMI were 83 kg/m2. There were two patients with
laparoscopic GSR and two with open due to insufficient pneumoperitoneum.
Three patients preoperative were in stage 3 of Edmonton Obesity Staging
System (EOSS) and one in stage 4. Three patients had excellent weight loss
and resolution of comorbidities (from 3 to 108 months), while one patient
with laparoscopic GSR during 15 months did not reach satisfactory result,
furthermore second operation have been suggested.
Conclusion:
GSR in MO patients could achieve good result both in short and
in long term. Once prepared for procedure, on operative table, GSR procedure
should be proceeding even in laparotomy needs. EOSS stage has been
improved in all operated MO patients. Further studies will clarify role of GSR
in MO patients.
Biography
Miroslav D Ilic has completed his PhD from University of Novi
Sad in field of Hepato/Biliary/Pacreatic Surgery. He is the
Director of Centre for Esophageal and Laparoscopic Surgery
in Clinic for Thoracic Surgery, Institute for Lung Diseases in Sr.
Kamenica. He is the founder of Alma Mons Course in Bariatric
Surgery. He published 25 papers in literature as well as several
books in Surgery.
drmiroslavilic@gmail.comGastric sleeve resection in mega obese
Miroslav D Ilic
1
, Srdjan Putnik
2
and Mia Manojlovic
3
1
University of Novi Sad, Serbia
2
General Hospital Vrsac, Serbia
3
University of Novi Sad
Miroslav D Ilic et al., J Clin Gastroenterol Hepatol 2018, Volume: 2
DOI: 10.21767/2575-7733-C1-002




